1. Home
  2. ASBPW vs CPF Comparison

ASBPW vs CPF Comparison

Compare ASBPW & CPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASBPW
  • CPF
  • Stock Information
  • Founded
  • ASBPW N/A
  • CPF 1954
  • Country
  • ASBPW United States
  • CPF United States
  • Employees
  • ASBPW N/A
  • CPF N/A
  • Industry
  • ASBPW Biotechnology: Pharmaceutical Preparations
  • CPF Major Banks
  • Sector
  • ASBPW Health Care
  • CPF Finance
  • Exchange
  • ASBPW Nasdaq
  • CPF Nasdaq
  • Market Cap
  • ASBPW N/A
  • CPF N/A
  • IPO Year
  • ASBPW 2022
  • CPF N/A
  • Fundamental
  • Price
  • ASBPW N/A
  • CPF $25.11
  • Analyst Decision
  • ASBPW
  • CPF Buy
  • Analyst Count
  • ASBPW 0
  • CPF 1
  • Target Price
  • ASBPW N/A
  • CPF $30.00
  • AVG Volume (30 Days)
  • ASBPW N/A
  • CPF 187.9K
  • Earning Date
  • ASBPW N/A
  • CPF 04-23-2025
  • Dividend Yield
  • ASBPW N/A
  • CPF 4.29%
  • EPS Growth
  • ASBPW N/A
  • CPF N/A
  • EPS
  • ASBPW N/A
  • CPF 1.97
  • Revenue
  • ASBPW N/A
  • CPF $240,575,000.00
  • Revenue This Year
  • ASBPW N/A
  • CPF N/A
  • Revenue Next Year
  • ASBPW N/A
  • CPF $6.49
  • P/E Ratio
  • ASBPW N/A
  • CPF $12.75
  • Revenue Growth
  • ASBPW N/A
  • CPF N/A
  • 52 Week Low
  • ASBPW N/A
  • CPF $18.60
  • 52 Week High
  • ASBPW N/A
  • CPF $33.25
  • Technical
  • Relative Strength Index (RSI)
  • ASBPW N/A
  • CPF 43.15
  • Support Level
  • ASBPW N/A
  • CPF $23.42
  • Resistance Level
  • ASBPW N/A
  • CPF $25.09
  • Average True Range (ATR)
  • ASBPW 0.00
  • CPF 1.05
  • MACD
  • ASBPW 0.00
  • CPF 0.03
  • Stochastic Oscillator
  • ASBPW 0.00
  • CPF 46.54

About ASBPW Aspire Biopharma Holdings Inc. Warrant

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: